A B R A H A M e t al order. American Journal of Psychiatry, 156. 585- 588. Belanoff, J. K., Flore*, B. H., Kalezhan, M , et al (2001) Rapid reversal of psychotic depres­ sion using mifepristone. Journal of Oinical Psy- chopharmacology, 21. 516-521. Brown, E. S., Bobadilla, L. & Rush, A . J. (2001) Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review. Bipolar Disorder, 3. 23-29. Cardno, A. G., Rljsdijk, F. V., Sham, P. C , et al (2002) A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry. 159. 539-545. Carroll. B. J., Curtis, G. C . & Mendels, j . (1976) Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Archives of General Psychiatry, 33. 1051- 1058. Cervantes, P., Gelber, S., Kin, F. N , et al (2001) Circadian secretion of Cortisol in bipolar disorder. J Psychiatry Neurosci, 26, 411-416. Cole, T. J., Blendy, J. A., Monaghan, A . P, et al (1995) Targeted disruption of the glucocor­ ticoid receptor gene blocks adrenergic chroma­ ffin cell development and severely retards lung maturation. Genes Dev, 9, 1608-1621. Cole.T. J., Myles, K., Purton.J. F„ et al (2001) GRKO mice express an aberrant dexametha- sone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant. Molecular & Cellular Endocrinology. 173. 193-202. Coplan, J. D., Andrews, M. W., Rosenblum, L. A., et of (1996) Persistent elevations of cerebrospinal fluid concentrations of corticotro- pin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety dis­ orders. Proceedings of the National Academy of Sciences USA, 93. 1619-1623. Davis, M. (1992) The role of the amygdala in fear and anxiety. Annual Review of Neurosdence. 15. 353-375. De Kloet,E. R.,Oitzl, M . S . * Joels, M.(1993) Functional implications of brain corticosteroid receptor diversity. Cellular It Molecular Neuro­ biology. 13. 433-455. De Kloet, E. R. & Reul, J. M. (1987) Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the het­ erogeneity of brain receptor systems. Psvchoneuroendocrino/ogy. 12. 83-105. De Kloet, E. R.. Vreugdenhil, E., Oitzl, M. S , et al (1998) Brain corticosteroid receptor balance in health and disease. Endocrine Reviews, 19. 269-301. Graham, P. M., Booth, J., Boranga, G , et of Jones, M. T., Gillham, B., Campbell, E. A , et (1982) The dexamethasone suppression test in al (1987) Pharmacology of neural pathways mania. Journal of Affective Disorders, 4, 201 -211. affecting CRH secretion. Ann N Y Acad Sa, 512, Harris, T. O., Borsanyi, S., Messari, S , et al (2000) Morning Cortisol as a risk factor for subsequent major depressive disorder in adult women. British Journal of Psychiatry, 177, 505- 510. H e i m , C , Newport, D. J., Bonsall, R., et of (2001) Altered pituitary-adrenal axis responses t o provocative challenge tests in adult survivors of childhood abuse. American Journal of Psychia­ try, 158, 575-581. H e i m , C , Newport, D. J., Miller, A. H., et al (2000) Long-term neuroendocrine effects of childhood maltreatment. JAMA, 284, 2321. Heuser, I. J., Schweiger, U., Gotthardt, U , et al (1996) Pituitary-adrenal-system regulation and psychopathology during amitriptyline treat­ ment in elderly depressed patients and normal comparison subjects. American Journal of Psy­ chiatry, 153, 93-99. Heuser, I. J., Yassouridis, A. 8< Holsboer, F. (1994) The combined dexamethasone/CRH test a refined laboratory test for psychiatric disor­ ders. Journal of Psychiatric Research, 28, 341-356. Hoyberg, O. J., W i k , G., Mehtonen, O. P, et al (2002) Org 34517, a selective glucocorticoid receptor antagonist with potent antidepressant Inskip, H., Harris, E. & Barraclough, B. (1998) Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. British Journal of Psychiatry, 172, 35-37. Jacobson, L. & Sapolsky, R. (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endo­ crine Reviews, 12, 118-134. Jaeckle, R. S., Kathol, R. G., Lopez, J. F, et al (1987) Enhanced adrenal sensitivity to exog­ enous cosyntropin (ACTH alpha 1-24) stimula­ tion in major depression. Relationship to dex­ amethasone suppression test results. Archives of General Psychiatry, 44, 233-240. 162-175. Kaminska, M., Harris, J., Gijsbers, K , et al (2000) Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticoster- one on dentate gyrus LTP. Implications for depression. Brain Research Bulletin, 52, 229-234. Kay, J. H., AHshuier, L. L., Ventura, J , et al (1999) Prevalence of axis II comorbidity in bipolar patients with and without alcohol use disorders. Ann Clin Psychiatry, I I , 187-195. Keller, M. B.. Lavori, P. W., Mueller, T. I , et of (1992) Time t o recovery, chronicity, and levels Dean, C . E. (2000) Prasterone (DHEA) and mania. Ann Pharmacother, 34, 1419-1422. DeBattista, C , Posener, J., Kalehzan, B , et al (2000) Acute Antidepressant Effects of Intra­ venous Hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study. American Journal of Psychiatry, 157, 1334-1337. Dubrovsky, B. (1993) Effects of adrenal cortex hormones on limbic structures: some experimen­ tal and clinical correlations related to depression. J Psychiatry Neurosci, 18, 4-16. Dunn, A. j . & Berridge, C. W . (1990) Physi­ ological and behavioral responses to corticotro- pin-releasing factor administration: is CR.F a mediator of anxiety or stress responses? Brain Research - Reviews, 15, 71-100. Erkut, Z . A., Pool, C . & Swaab, D. F. (1998) Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. Journal of Clinical Endocrinology and Metabolism, 83. 2066-2073. Ferrier, I. N., Stanton, B. R., Kelly, T. P, et al (1999) Neuropsychological function in euthymic patients with bipolar disorder. British Journal of Psychiatry, 175, 246-251. Gibbons, J. (1964) Cortisol secretion rate in depressive illness. Archives of General Psychiatry, activity: first clinical results. The International 10, 572-575. Journal of Neuropsychopharmocology, 5, SI48. Gold, P. W , Chrousos, G., Kellner, C , et al (1984) Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. American Journal of Psychiatry, 141, 619-627. Goodwin, F. & Jamison, K. (1990) Manic Depressive Illness. New York: Oxford University Press. Goodwin, F. K. (1984) The biology of depres­ sion: conceptual issues. Advances in Biochemical Psychopharmacology, 39, 11 -26. Gould, E.,Tanapat, P., Rydel.T, et of (2000) Regulation of hippocampal neurogenesis in adult­ hood. Biological Psychiatry, 48, 715-720. Greden, J. F., DeVigne, J. P., Albala, A. A , et al (1982) Serial dexamethasone suppression tests among rapidly cycling bipolar patients. Biological Psychiatry, 17, 455-462. Griebel, G., Simiand, J., Serradeil-Le Gal, C , et al (2002) Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V I b receptor antagonist. SSRI494I5, suggest an in­ novative approach for the treatment of stress- related disorders. Proceedings of the National Academy of Sciences USA. 16. 16. (12)